Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...

A new tool can help physicians determine which patients with localized pancreatic neuroendocrine tumors (PanNETs) have an ...

Rumors of MTV’s demise have been greatly exaggerated. In October, it was announced that many of MTV’s subchannels in Europe ...

Rafta, a senior Shih Tzu abandoned in neglect, was saved by rescue after suffering a painful mass. He's now healing, ...

In July, the FDA issued a complete response letter (CRL) for Replimune's biologics license application for RP1 (vusolimogene ...

Determined to get answers, Glass flew to Bethesda, Maryland, just eight days after the call. At the NIH, she underwent a full-body MRI, met with an oncologist, and had comprehensive blood work done.

University of Iowa doctoral student Katie Colling is making progress in identifying hormones that are effective at combating uterine cancer.

Pancreatic cancer is one of the deadliest cancers, largely because it is usually discovered only after it has spread to other ...

Wall Street analysts have painted a tantalizing picture of triple-digit upside potential for some of this year’s worst-performing biotech names. Yet investors may want to temper their excitement.

Cancer is no longer considered untreatable, yet improving the accuracy and timeliness of diagnostics and treatment remains ...

At Health First, this innovation is being brought to life through partners like NextGen Pathology, delivering precise diagnostic services.

This work was supported by the National Natural Science Foundation of China (Grant No. 82373113, XJ), Shenyang Breast Cancer ...